Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$14.44 - $18.83 $587,708 - $766,380
-40,700 Reduced 77.52%
11,800 $176,000
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $979,124 - $1.21 Million
52,500 New
52,500 $1 Million
Q1 2022

May 17, 2022

BUY
$30.45 - $39.36 $654,370 - $845,846
21,490 Added 16.07%
155,200 $5.42 Million
Q4 2021

Feb 15, 2022

BUY
$28.67 - $37.13 $1.25 Million - $1.62 Million
43,740 Added 48.62%
133,710 $4.07 Million
Q3 2021

Nov 16, 2021

BUY
$28.63 - $35.64 $1.71 Million - $2.13 Million
59,890 Added 199.1%
89,970 $2.95 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $855,776 - $1.14 Million
30,080 New
30,080 $910,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.